FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022085815> ?p ?o ?g. }

• W2022085815 endingPage "1934" @default.
• W2022085815 startingPage "1929" @default.
• W2022085815 abstract "Distal esophageal (Schatzki's) rings are a frequent cause of dysphagia. Bougienage is generally effective, but relapses are common. The aim of this study was to evaluate the effect of long-term antisecretory therapy on the relapse rate of lower esophageal rings after successful bougienage with Savary dilators.The study was performed on 44 consecutive patients with symptomatic Schatzki's rings, detected endoscopically, and/or radiologically. Graded esophageal dilation was performed as an outpatient procedure in a single session. After appropriate assessment with esophageal manometry and 24-h ambulatory esophageal pH monitoring, patients with documented GERD (n = 14) were treated with long-term omeprazole therapy. The remaining patients were blindly randomized to receive maintenance treatment with either omeprazole (group A-15 patients) or placebo (group B-15 patients). The necessity for redilation after documentation of the ring with endoscopy and/or radiology was considered as a relapse of the ring. The relapse rate was evaluated in all groups.All bougienages were performed without significant side effects. Eight patients (8 of 44, 18.2%) had one or more relapses after a mean (SD) of 19.0 (10.1) months. Patients with (n = 14) or without (n = 30) GERD were comparable with respect to sex, age, body mass index, cigarette and alcohol consumption, diameter of the esophageal lumen at the level of the ring, resting lower esophageal sphincter pressure, duration of dysphagia, need for taking antacids during the follow-up period, and duration of follow-up. There were no recurrences of Schatzki's ring in the group of patients with documented GERD (follow-up [mean +/- SD]: 43.8 +/- 9.3 months, range: 27-62). In group A (follow-up [mean +/- SD]: 37.1 +/- 17.1 months, range: 11-66), one patient relapsed after 13 months, while in group B (follow-up [mean +/- SD]: 34.3 +/- 14.6 months, range: 10-58), seven patients relapsed after a mean (SD) of 19.9 (10.6) months. The actuarial probability of relapse was higher in patients without therapy (group B) (p= 0.008).Our data support the hypothesis that, in patients with symptomatic Schatzki's rings, acid suppressive maintenance therapy after bougienage may prevent relapse of the ring." @default.
• W2022085815 created "2016-06-24" @default.
• W2022085815 creator A5021790064 @default.
• W2022085815 creator A5034242339 @default.
• W2022085815 creator A5047725521 @default.
• W2022085815 creator A5048689360 @default.
• W2022085815 creator A5059180467 @default.
• W2022085815 creator A5068433446 @default.
• W2022085815 creator A5075258840 @default.
• W2022085815 creator A5087791098 @default.
• W2022085815 creator A5088308417 @default.
• W2022085815 date "2005-09-01" @default.
• W2022085815 modified "2023-09-24" @default.
• W2022085815 title "Long-Term Acid Suppressive Therapy May Prevent the Relapse of Lower Esophageal (Schatzki's) Rings: A Prospective, Randomized, Placebo-Controlled Study" @default.
• W2022085815 cites W1544979452 @default.
• W2022085815 cites W1600313688 @default.
• W2022085815 cites W1968800582 @default.
• W2022085815 cites W1982655951 @default.
• W2022085815 cites W2003394476 @default.
• W2022085815 cites W2009854210 @default.
• W2022085815 cites W2016260325 @default.
• W2022085815 cites W2045293964 @default.
• W2022085815 cites W2054361249 @default.
• W2022085815 cites W2071619353 @default.
• W2022085815 cites W2073636203 @default.
• W2022085815 cites W2085685186 @default.
• W2022085815 cites W2088813746 @default.
• W2022085815 cites W2116724593 @default.
• W2022085815 cites W2152305723 @default.
• W2022085815 cites W2157072389 @default.
• W2022085815 cites W2335039949 @default.
• W2022085815 cites W4231999202 @default.
• W2022085815 cites W4236150867 @default.
• W2022085815 cites W4252623563 @default.
• W2022085815 doi "https://doi.org/10.1111/j.1572-0241.2005.41184.x" @default.
• W2022085815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16128935" @default.
• W2022085815 hasPublicationYear "2005" @default.
• W2022085815 type Work @default.
• W2022085815 sameAs 2022085815 @default.
• W2022085815 citedByCount "43" @default.
• W2022085815 countsByYear W20220858152012 @default.
• W2022085815 countsByYear W20220858152013 @default.
• W2022085815 countsByYear W20220858152014 @default.
• W2022085815 countsByYear W20220858152015 @default.
• W2022085815 countsByYear W20220858152016 @default.
• W2022085815 countsByYear W20220858152017 @default.
• W2022085815 countsByYear W20220858152018 @default.
• W2022085815 countsByYear W20220858152019 @default.
• W2022085815 countsByYear W20220858152020 @default.
• W2022085815 countsByYear W20220858152021 @default.
• W2022085815 countsByYear W20220858152023 @default.
• W2022085815 crossrefType "journal-article" @default.
• W2022085815 hasAuthorship W2022085815A5021790064 @default.
• W2022085815 hasAuthorship W2022085815A5034242339 @default.
• W2022085815 hasAuthorship W2022085815A5047725521 @default.
• W2022085815 hasAuthorship W2022085815A5048689360 @default.
• W2022085815 hasAuthorship W2022085815A5059180467 @default.
• W2022085815 hasAuthorship W2022085815A5068433446 @default.
• W2022085815 hasAuthorship W2022085815A5075258840 @default.
• W2022085815 hasAuthorship W2022085815A5087791098 @default.
• W2022085815 hasAuthorship W2022085815A5088308417 @default.
• W2022085815 hasConcept C126322002 @default.
• W2022085815 hasConcept C141071460 @default.
• W2022085815 hasConcept C142724271 @default.
• W2022085815 hasConcept C168563851 @default.
• W2022085815 hasConcept C204787440 @default.
• W2022085815 hasConcept C27081682 @default.
• W2022085815 hasConcept C2777014526 @default.
• W2022085815 hasConcept C2777498785 @default.
• W2022085815 hasConcept C2777819096 @default.
• W2022085815 hasConcept C2779134260 @default.
• W2022085815 hasConcept C2780323790 @default.
• W2022085815 hasConcept C2780596822 @default.
• W2022085815 hasConcept C35785553 @default.
• W2022085815 hasConcept C43270747 @default.
• W2022085815 hasConcept C71924100 @default.
• W2022085815 hasConcept C90924648 @default.
• W2022085815 hasConceptScore W2022085815C126322002 @default.
• W2022085815 hasConceptScore W2022085815C141071460 @default.
• W2022085815 hasConceptScore W2022085815C142724271 @default.
• W2022085815 hasConceptScore W2022085815C168563851 @default.
• W2022085815 hasConceptScore W2022085815C204787440 @default.
• W2022085815 hasConceptScore W2022085815C27081682 @default.
• W2022085815 hasConceptScore W2022085815C2777014526 @default.
• W2022085815 hasConceptScore W2022085815C2777498785 @default.
• W2022085815 hasConceptScore W2022085815C2777819096 @default.
• W2022085815 hasConceptScore W2022085815C2779134260 @default.
• W2022085815 hasConceptScore W2022085815C2780323790 @default.
• W2022085815 hasConceptScore W2022085815C2780596822 @default.
• W2022085815 hasConceptScore W2022085815C35785553 @default.
• W2022085815 hasConceptScore W2022085815C43270747 @default.
• W2022085815 hasConceptScore W2022085815C71924100 @default.
• W2022085815 hasConceptScore W2022085815C90924648 @default.
• W2022085815 hasIssue "9" @default.
• W2022085815 hasLocation W20220858151 @default.
• W2022085815 hasLocation W20220858152 @default.
• W2022085815 hasOpenAccess W2022085815 @default.
• W2022085815 hasPrimaryLocation W20220858151 @default.

• next